BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay
Written by Black Hot Fire Network on September 26, 2022
Research Use Only (RUO) assay now globally available for BD MAX™ System
FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) ( NYSE: BDX), a leading global medical technology company, and CerTest Biotec today announced their newly developed molecular polymerase chain reaction (PCR) assay for monkeypox virus is now commercially available globally, including in the United States, for research use only applications by laboratories.
